Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria

Lancet

Volumn 354, Issue 9176, 1999, Pages 359-364

  Ruggenenti, Piero ^a   Perna, Annalisa ^a   Gherardi, Giulia ^a   Garini, Giovanni ^b   Zoccali, Carmine ^c   Salvadori, Maurizio ^d   Scolari, Francesco ^e   Schena, Francesco Paolo ^f   Remuzzi, Giuseppe ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b Azienda Ospedaliero Universitaria Di Parma   (Italy)

^c Div Nefrologia Ctro Fisiol C   (Italy)

^d CAREGGI UNIVERSITY HOSPITAL   (Italy)

^e SPEDALI CIVILI   (Italy)

^f POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; RAMIPRIL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL;

EID: 0033620788     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)10363-X     Document Type: Article

References (18)

1. A long-term, randomized clinical trial to evaluate the effects of ramipril on the evolution of renal function in chronic nephropathies. J Nephrol. 3:1991;193-202.
2. Remuzzi G., Ruggenenti P., Benigni A. Understanding the nature of renal disease progression. Kidney Int. 51:1997;2-15.
3. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet. 349:1997;1857-1863.
4. Ruggenenti P., Perna A., Gherardi G., Gaspari F., Benini R., Remuzzi G. Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Lancet. 352:1998;1252-1256.
5. Gaspari F., Perico N., Ruggenenti P.et al. Plasma clearance of nonradioactive iohexol as a measure of glomerular filtration rate in patients with normal or impaired renal function. J Am Soc Nephrol. 6:1995;1-7.
6. Rice E.W.Improved biuret procedure for determination of urinary total proteins in clinical proteinuria Clin Chem. 21:1975;398-401.
7. Parving H.H., Andersen A.R., Smidt U.M., Hommel E., Mathiesen E.R., Svendsen P.A. Effect of antihypertensive treatment on kidney function in diabetic nephropathy. BMJ. 294:1987;1443-1447.
8. Lewis E.J., Hunsicker L.G., Bain R.P., Rhode R.D. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med. 329:1993;1456-1462.
9. Peterson J.C., Adler S., Burkan J.M.et al. Blood pressure control, proteinuria, and the progression of renal disease. Ann Intern Med. 123:1995;754-762.
10. Haybittle J.L. Repeated assessments of results in clinical trials of cancer treatment. Br J Radiol. 44:1971;793-797.
11. Maschio G., Alberti D., Janin G.et al. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med. 334:1996;939-945.
12. Ruggenenti P., Perna A., Benini R.et al. In chronic nephropathies prolonged ACE inhibition can induce remission:dynamics of time-dependent changes in GFR. J Am Soc Nephrol. 10:1999;997-1006.
13. Greene T., Beck G.Y., Gassman Y.Y., Kutner M.H., Paranandi L., Wang S. Comparison of time-to-event and slope-based analyses in nephrology clinical trials. Control Clin Trials. 16:1995;655. (abstr).
14. Remuzzi G., Bertani T. The pathophysiology of progressive nephropathies. N Engl J Med. 339:1998;1448-1456.
15. Apperloo A.J., de Zeeuw D., de Joung P.E. Short-term antiproteinuric response to antihypertensive treatment predicts long-term GFR decline in patients with non-diabetic renal disease. Kidney Int. 45(45):1994;174-178.
16. Rossing P., Hommel E., Smidt U.M., Parving H.H. Reduction in albuminuria predicts diminished progression in diabetic nephropathy. Kidney Int. 45(45):1994;145-149.
17. Remuzzi A., Puntorieri S., Battaglia C., Bertani T., Remuzzi G. Angiotensin converting-enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat. J Clin Invest. 85:1990;541-549.
18. Abbate M., Zoja C., Corna D., Capitanio M., Bertani T., Remuzzi G. In progressive nephropathies, overload of tubular cells with filtered proteins translates glomerular permeability dysfunction into cellular signals of interstitial inflammation. J Am Soc Nephrol. 9:1998;1213-1224.